麻豆传媒

Brain Canada is pleased to be partnering with Alzheimer鈥檚 Association (ALZ) to launch the Advancing Research on Care & Outcome Measurement 3.0 (ARCOM-3) funding program, an international and collaborative competition aimed at addressing significant gaps in care and outcome measurement, and providing an opportunity to advance research so that care providers can ensure that they are implementing evidence-based practices and achieving desired outcomes.聽

Areas of interest for this program include, but are not limited to, quality metrics, systems of care, translation of interventions, increasing diversity within research and clinical trials, risk reduction, development of novel methods of data collection or analysis, and novel measures to validate previously developed measures or evaluation of measures in diverse and underrepresented populations.聽聽

Through this partnership, Brain Canada will co-fund up to four Canadian-led teams. Each award is limited to USD $250,000 over a period of up to two years.聽聽

Click to view the Request for Applications.聽聽

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.聽

Internal Deadline

Letter of Intent: September 6, 2023 at 4:30pm
Full Application: November 15, 2023 at 4:30pm

Contact the聽grants facilitator聽for your faculty. For additional resources,聽click here for guidance聽on internal deadlines and submission processes.

Funder Deadline

Letter of Intent: September 20, 2023 at 6pm AST
Full Application: November 29, 2023 at 6pm AST